Rutland Region Collaborative Aco, Llc | |
275 Route 30 N Bomoseen VT 05732-9647 | |
(802) 468-5641 | |
(802) 468-2923 |
Full Name | Rutland Region Collaborative Aco, Llc |
---|---|
Speciality | Family Medicine |
Location | 275 Route 30 N, Bomoseen, Vermont |
Authorized Official Name and Position | Michael Gardner (FINANCE DIRECTOR) |
Authorized Official Contact | 8027733386 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Rutland Region Collaborative Aco, Llc 275 Route 30 N Bomoseen VT 05732-9647 Ph: (802) 468-5641 | Rutland Region Collaborative Aco, Llc 275 Route 30 N Bomoseen VT 05732-9647 Ph: (802) 468-5641 |
NPI Number | 1689949968 |
---|---|
Provider Enumeration Date | 03/20/2012 |
Last Update Date | 03/20/2012 |
Identifier | Type | State | Issuer |
---|---|---|---|
1689949968 | NPI | - | NPPES |
News Archive
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") is pleased to announce that it has completed its planned pre-clinical program for its lead product ATB-346 to support initial clinical studies in humans.
The U.S. Food and Drug Administration today warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protective membranes (meninges) that cover the brain and spinal cord not caused by bacterial infection.The agency is working with the drug's manufacturer, GlaxoSmithKline, to update the prescribing information and patient medication guide to include this risk.
Active lifestyle choices such as eating vegetables, exercising and quitting smoking can reduce the risk of chronic kidney disease, a new study led by researchers at Karolinska Institutet in Sweden and Griffith University in Australia, reports.
ObamaCare's cost-cutting board -; memorably called a "death panel" by Sarah Palin -; is facing growing opposition from Democrats who say it will harm people on Medicare. Former Democratic National Committee Chairman Howard Dean drew attention to the board designed to limit Medicare cost growth when he called for its repeal in an op-ed late last month (Viebeck 8/8).
Roche Molecular Systems, Inc. announced today that the U.S. Food & Drug Administration (FDA) cleared its new LightCycler® MRSA Advanced Test for the detection of methicillin-resistant Staphylococcus aureus (MRSA) for clinical use in the United States.
› Verified 1 days ago